97 related articles for article (PubMed ID: 36512307)
1. YBX1 is required for maintaining myeloid leukemia cell survival by regulating BCL2 stability in an m6A-dependent manner.
Feng M; Xie X; Han G; Zhang T; Li Y; Li Y; Yin R; Wang Q; Zhang T; Wang P; Hu J; Cheng Y; Gao Z; Wang J; Chang J; Cui M; Gao K; Chai J; Liu W; Guo C; Li S; Liu L; Zhou F; Chen J; Zhang H
Blood; 2021 Jul; 138(1):71-85. PubMed ID: 33763698
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the bone marrow niche in patients with chronic myeloid leukemia identifies CXCL14 as a new therapeutic option.
Dolinska M; Cai H; Månsson A; Shen J; Xiao P; Bouderlique T; Li X; Leonard E; Chang M; Gao Y; Medina JP; Kondo M; Sandhow L; Johansson AS; Deneberg S; Söderlund S; Jädersten M; Ungerstedt J; Tobiasson M; Östman A; Mustjoki S; Stenke L; Le Blanc K; Hellström-Lindberg E; Lehmann S; Ekblom M; Olsson-Strömberg U; Sigvardsson M; Qian H
Blood; 2023 Jul; 142(1):73-89. PubMed ID: 37018663
[TBL] [Abstract][Full Text] [Related]
3. Differential regulation of myeloid leukemias by the bone marrow microenvironment.
Krause DS; Fulzele K; Catic A; Sun CC; Dombkowski D; Hurley MP; Lezeau S; Attar E; Wu JY; Lin HY; Divieti-Pajevic P; Hasserjian RP; Schipani E; Van Etten RA; Scadden DT
Nat Med; 2013 Nov; 19(11):1513-7. PubMed ID: 24162813
[TBL] [Abstract][Full Text] [Related]
4. The leukaemia stem cell: similarities, differences and clinical prospects in CML and AML.
Vetrie D; Helgason GV; Copland M
Nat Rev Cancer; 2020 Mar; 20(3):158-173. PubMed ID: 31907378
[TBL] [Abstract][Full Text] [Related]
5. Discovery of survival factor for primitive chronic myeloid leukemia cells using induced pluripotent stem cells.
Suknuntha K; Ishii Y; Tao L; Hu K; McIntosh BE; Yang D; Swanson S; Stewart R; Wang JYJ; Thomson J; Slukvin I
Stem Cell Res; 2015 Nov; 15(3):678-693. PubMed ID: 26561938
[TBL] [Abstract][Full Text] [Related]
6. TET2-mediated mRNA demethylation regulates leukemia stem cell homing and self-renewal.
Li Y; Xue M; Deng X; Dong L; Nguyen LXT; Ren L; Han L; Li C; Xue J; Zhao Z; Li W; Qing Y; Shen C; Tan B; Chen Z; Leung K; Wang K; Swaminathan S; Li L; Wunderlich M; Mulloy JC; Li X; Chen H; Zhang B; Horne D; Rosen ST; Marcucci G; Xu M; Li Z; Wei M; Tian J; Shen B; Su R; Chen J
Cell Stem Cell; 2023 Aug; 30(8):1072-1090.e10. PubMed ID: 37541212
[TBL] [Abstract][Full Text] [Related]
7. Flow Cytometric Assessment of CD26-Positive Leukemic Stem Cells: A Rapid and Valuable Tool in the Diagnosis and Follow-Up of Chronic Myeloid Leukemia.
Kana S; John S; Basu D; Kar R; Nachiappa Ganesh R; Dubashi B
Cureus; 2024 Mar; 16(3):e56944. PubMed ID: 38665755
[TBL] [Abstract][Full Text] [Related]
8. Antileukemic potential of methylated indolequinone MAC681 through immunogenic necroptosis and PARP1 degradation.
Orlikova-Boyer B; Lorant A; Gajulapalli SR; Cerella C; Schnekenburger M; Lee JY; Paik JY; Lee Y; Siegel D; Ross D; Han BW; Nguyen TKY; Christov C; Kang HJ; Dicato M; Diederich M
Biomark Res; 2024 May; 12(1):47. PubMed ID: 38704604
[TBL] [Abstract][Full Text] [Related]
9. Investigating the Effects of a Synthetic Cannabinoid on the Pathogenesis of Leukemia and Leukemic Stem Cells: A New Therapeutic Approach.
Salcin H; Goker Bagca B; Alcitepe I; Biray Avci C; Aslan R; Annette Akgur S; Tezcanli Kaymaz B
Cannabis Cannabinoid Res; 2024 Feb; 9(1):212-222. PubMed ID: 35834597
[TBL] [Abstract][Full Text] [Related]
10. Temporal Single Cell Analysis of Leukemia Microenvironment Identifies Taurine-Taurine Transporter Axis as a Key Regulator of Myeloid Leukemia.
Rodems BJ; Sharma S; Baker CD; Kaszuba CM; Ito T; Liesveld JL; Calvi LM; Becker MW; Jordan CT; Ashton JM; Bajaj J
bioRxiv; 2024 May; ():. PubMed ID: 38798540
[TBL] [Abstract][Full Text] [Related]
11. m6A writer WTAP targets NRF2 to accelerate bladder cancer malignancy via m6A-dependent ferroptosis regulation.
Wang K; Wang G; Li G; Zhang W; Wang Y; Lin X; Han C; Chen H; Shi L; Reheman A; Li J; Li Z; Yang X
Apoptosis; 2023 Apr; 28(3-4):627-638. PubMed ID: 36719469
[TBL] [Abstract][Full Text] [Related]
12. Identification and quantification of DNA N
Lyu C; Wang HD; Lai W; Wang H
Curr Opin Chem Biol; 2023 Apr; 73():102259. PubMed ID: 36652775
[TBL] [Abstract][Full Text] [Related]
13. RNA modifications in hematological malignancies.
Jin Z; MacPherson K; Liu Z; Vu LP
Int J Hematol; 2023 Jun; 117(6):807-820. PubMed ID: 36929506
[TBL] [Abstract][Full Text] [Related]
14. Decoding m
Cheng Y; Gao Z; Zhang T; Wang Y; Xie X; Han G; Li Y; Yin R; Chen Y; Wang P; Hu J; Zhang T; Guo C; Chai J; Wang J; Cui M; Gao K; Liu W; Yao S; Lu P; Cao Z; Zheng Y; Chang J; Liu Z; Song Q; Li W; Zhou F; Zhang H
Cell Stem Cell; 2023 Jan; 30(1):69-85.e7. PubMed ID: 36574771
[TBL] [Abstract][Full Text] [Related]
15. Integrated single-cell and spatial transcriptomic analysis reveals YBX1 drives immune regulation in GBM progression.
Ge Y; Weng H; Sun Y; Wu M
Heliyon; 2024 Apr; 10(8):e29451. PubMed ID: 38628755
[TBL] [Abstract][Full Text] [Related]
16. [Not Available].
Liu L; Chen Y; Zhang T; Cui G; Wang W; Zhang G; Li J; Zhang Y; Wang Y; Zou Y; Ren Z; Xue W; Sun R
Adv Sci (Weinh); 2024 May; 11(20):e2302379. PubMed ID: 38566431
[TBL] [Abstract][Full Text] [Related]
17. Y-Box Binding Protein 1: Unraveling the Multifaceted Role in Cancer Development and Therapeutic Potential.
Dinh NTM; Nguyen TM; Park MK; Lee CH
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255791
[TBL] [Abstract][Full Text] [Related]
18. Aberrant RNA m
Shen LT; Che LR; He Z; Lu Q; Chen DF; Qin ZY; Wang B
Cell Death Dis; 2023 Apr; 14(4):236. PubMed ID: 37015927
[TBL] [Abstract][Full Text] [Related]
19. YBX1 regulates the survival of chronic myeloid leukemia stem cells by modulating m
Chai J; Wang Q; Qiu Q; Han G; Chen Y; Li W; Zhang H
Cell Oncol (Dordr); 2023 Apr; 46(2):451-464. PubMed ID: 36512307
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]